Pennsylvania HB2652: An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

What the bill says

Amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

From the introduced text, June 22, 2026:

Amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Title 40 of the Pennsylvania Consolidated Statutes is amended by adding a chapter to read: CHAPTER 52 PRESCRIPTION DRUG COST CREDITS IN HEALTH INSURANCE Sec. 5201. Scope of chapter. 5202. Definitions. 5203. Prescription drug cost credit requirement. 5204. Exceptions. 5205. Protections. 5206. Submission process. 5207. Notice. 5208. Exemption. 5209. Regulations. 5210. Enforcement. § 5201. Scope of chapter. This chapter relates to the crediting of out-of-pocket costs paid for prescription drugs toward health plan cost-sharing. § 5202. Definitions. The following words and phrases when used in this chapter shall have the meanings given to them in this section unless the context clearly indicates otherwise: "Commissioner." The Insurance Commissioner of the Commonwealth. "Cost-sharing." As follows: (1) The share of the health care costs covered by a health benefit plan that a covered person pays out-of-pocket. (2) The term includes deductibles, coinsurance, copayments and similar charges. (3) The term does not include premiums, balance billed amounts from an out-of-network health care provider or the cost of noncovered services except as specified in this chapter. "Covered person." A policyholder, subscriber or other individual who is entitled to receive health …

Read the full official text

Sponsors

• Emily Kinkead (D, 20) · primary sponsor
• Jeanne McNeill (D, 133)
• Tarah Probst (D, 189)
• Manuel Guzman (D, 127)
• Kristine Howard (D, 167)
• Benjamin Sanchez (D, 153)
• Joseph Hohenstein (D, 177)
• DEASY JR., DANIEL J. (D, 027)
• Danielle Otten (D, 155)
• Dan Williams (D, 74)
• Joseph Ciresi (D, 146)
• Valerie Gaydos (R, 44)

Latest actions

1. September 8, 2026: Laid on the table, Sept. 8, 2026
2. September 8, 2026: Re-reported as committed, Sept. 8, 2026
3. June 24, 2026: Re-committed to RULES, June 24, 2026
4. June 24, 2026: First consideration, June 24, 2026
5. June 24, 2026: Reported as amended, June 24, 2026
6. June 22, 2026: Referred to INSURANCE, June 22, 2026

Votes

• House Insurance: Report Bill As Amended (June 24, 2026): 14 yea, 12 nay, passed
• House Insurance: Adopt Amendment (June 24, 2026): 26 yea, 0 nay, passed

Common questions

What is HB2652?

HB2652 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

What does HB2652 do?

In its own words: Amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

What is the status of HB2652?

In committee as of September 8, 2026. Latest action: Laid on the table, Sept. 8, 2026 (September 8, 2026).

Who sponsored HB2652?

Emily Kinkead (D, 20), with 11 co-sponsors.

Where is the official record for HB2652?

On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hb2652